PALMOPLANTAR KERATODERMA, NONEPIDERMOLYTIC, FOCAL OR DIFFUSE
|
0.700 |
GeneticVariation
|
disease |
UNIPROT |
Collapse of the keratin filament network through the expression of mutant keratin 6c observed in a case of focal plantar keratoderma.
|
23662636 |
2013 |
PALMOPLANTAR KERATODERMA, NONEPIDERMOLYTIC, FOCAL OR DIFFUSE
|
0.700 |
GermlineCausalMutation
|
disease |
ORPHANET |
Diffuse and focal palmoplantar keratoderma can be caused by a keratin 6c mutation.
|
21801157 |
2011 |
PALMOPLANTAR KERATODERMA, NONEPIDERMOLYTIC, FOCAL OR DIFFUSE
|
0.700 |
GeneticVariation
|
disease |
UNIPROT |
Diffuse and focal palmoplantar keratoderma can be caused by a keratin 6c mutation.
|
21801157 |
2011 |
PALMOPLANTAR KERATODERMA, NONEPIDERMOLYTIC, FOCAL OR DIFFUSE
|
0.700 |
GermlineCausalMutation
|
disease |
ORPHANET |
Keratin K6c mutations cause focal palmoplantar keratoderma.
|
19609311 |
2010 |
PALMOPLANTAR KERATODERMA, NONEPIDERMOLYTIC, FOCAL OR DIFFUSE
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Keratin K6c mutations cause focal palmoplantar keratoderma.
|
19609311 |
2010 |
PALMOPLANTAR KERATODERMA, NONEPIDERMOLYTIC, FOCAL OR DIFFUSE
|
0.700 |
GeneticVariation
|
disease |
UNIPROT |
Keratin K6c mutations cause focal palmoplantar keratoderma.
|
19609311 |
2010 |
PALMOPLANTAR KERATODERMA, NONEPIDERMOLYTIC, FOCAL OR DIFFUSE
|
0.700 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
PALMOPLANTAR KERATODERMA, NONEPIDERMOLYTIC, FOCAL OR DIFFUSE
|
0.700 |
Biomarker
|
disease |
CTD_human |
|
|
|
Keratoderma, Palmoplantar
|
0.410 |
GeneticVariation
|
disease |
BEFREE |
These findings strongly suggest that screening of patients with nonepidermolytic diffuse PPK, in whom the pathogenic mutations are yet to be determined, might identify mutations in KRT6C.
|
21801157 |
2011 |
Keratoderma, Palmoplantar
|
0.410 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
Keratoderma, Palmoplantar
|
0.410 |
Biomarker
|
disease |
HPO |
|
|
|
Dystrophia unguium
|
0.300 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Keratin K6c mutations cause focal palmoplantar keratoderma.
|
19609311 |
2010 |
Hepatomegaly
|
0.200 |
Biomarker
|
phenotype |
RGD |
Discriminating between adaptive and carcinogenic liver hypertrophy in rat studies using logistic ridge regression analysis of toxicogenomic data: The mode of action and predictive models.
|
28108177 |
2017 |
Hepatomegaly
|
0.200 |
Biomarker
|
phenotype |
CTD_rat |
Discriminating between adaptive and carcinogenic liver hypertrophy in rat studies using logistic ridge regression analysis of toxicogenomic data: The mode of action and predictive models.
|
28108177 |
2017 |
Acanthosis
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
PALMOPLANTAR KERATODERMA, NONEPIDERMOLYTIC, FOCAL 1
|
0.100 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Pachyonychia Congenita
|
0.040 |
GeneticVariation
|
disease |
BEFREE |
Pachyonychia congenita (PC) is a group of autosomal dominant disorders caused by mutations in one of 5 keratin genes (KRT6A, KRT6B, KRT6C, KRT16, or KRT17).
|
31823354 |
2020 |
Pachyonychia Congenita
|
0.040 |
GeneticVariation
|
disease |
BEFREE |
Pachyonychia congenita (PC) is a rare autosomal dominant genodermatosis caused by a mutation in any one of 5 keratin genes (KRT6A, KRT6B, KRT6C, KRT16 or KRT17) featuring painful palmoplantar keratoderma, variable nail dystrophy, cysts, follicular hyperkeratosis, and often oral leukokeratosis.
|
31777952 |
2020 |
Pachyonychia Congenita
|
0.040 |
GeneticVariation
|
disease |
BEFREE |
Finally, this PC-associated substitution as well as more frequent caries-associated SNPs, found in two of the KRT6 genes, that result in rs28538343" genes_norm="286887;3854;3868">p.Ser143Asn substitution (rs28538343 in KRT6B and rs151117600 in KRT6C), alter the assembly of K6 filaments in ameloblast-like cells.
|
29357356 |
2018 |
Pachyonychia Congenita
|
0.040 |
GeneticVariation
|
disease |
BEFREE |
Twenty years have elapsed since keratin mutations were linked to cutaneous genodermatoses, and we now know that they cause 40 different genetic disorders.In this issue, Wilson et al. have identified KRT6C mutations in patients with focal palmoplantar keratoderma (FPPK), but debate concerning overlapping phenotypes between FPPK and pachyonychia congenita (PC) will continue because only one family has nail involvement.
|
20081885 |
2010 |
Hyperkeratosis of the palms and soles and esophageal papillomas
|
0.030 |
GeneticVariation
|
disease |
BEFREE |
Recently, mutations of KRT6C were identified in families with focal PPK alone.
|
23662636 |
2013 |
Hyperkeratosis of the palms and soles and esophageal papillomas
|
0.030 |
GeneticVariation
|
disease |
BEFREE |
Mutations in the KRT6A or KRT16 gene cause pachyonychia congenita type 1 (PC-1), while mutations in KRT16 or KRT6C underlie focal palmoplantar keratoderma (FPPK).
|
22668561 |
2013 |
Hyperkeratosis of the palms and soles and esophageal papillomas
|
0.030 |
GeneticVariation
|
disease |
BEFREE |
Twenty years have elapsed since keratin mutations were linked to cutaneous genodermatoses, and we now know that they cause 40 different genetic disorders.In this issue, Wilson et al. have identified KRT6C mutations in patients with focal palmoplantar keratoderma (FPPK), but debate concerning overlapping phenotypes between FPPK and pachyonychia congenita (PC) will continue because only one family has nail involvement.
|
20081885 |
2010 |
Dental caries
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Using genetic and intraoral examination data from 573 adults and 449 children, we identified several missense polymorphisms in KRT6A, KRT6B and KRT6C that lead to a higher risk for dental caries.
|
29357356 |
2018 |
ovarian neoplasm
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
KRT5 and KRT6 (KRT6A, KRT6B & KRT6C) gene expression was assessed in publically available serous ovarian cancer data sets, ovarian cancer cell lines and primary serous ovarian cancer cells.
|
28147318 |
2017 |